These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 17327385)

  • 1. Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention.
    Stefan N; Thamer C; Staiger H; Machicao F; Machann J; Schick F; Venter C; Niess A; Laakso M; Fritsche A; Häring HU
    J Clin Endocrinol Metab; 2007 May; 92(5):1827-33. PubMed ID: 17327385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in PPARD determine the change in body composition during lifestyle intervention: a whole-body magnetic resonance study.
    Thamer C; Machann J; Stefan N; Schäfer SA; Machicao F; Staiger H; Laakso M; Böttcher M; Claussen C; Schick F; Fritsche A; Haring HU
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1497-500. PubMed ID: 18252792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there an interaction between PPARD T294C and PPARGC1A Gly482Ser polymorphisms and human endurance performance?
    Eynon N; Meckel Y; Alves AJ; Yamin C; Sagiv M; Goldhammer E; Sagiv M
    Exp Physiol; 2009 Nov; 94(11):1147-52. PubMed ID: 19666693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.
    Andrulionyte L; Peltola P; Chiasson JL; Laakso M;
    Diabetes; 2006 Jul; 55(7):2148-52. PubMed ID: 16804087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE I/D, ACTN3 R577X, PPARD T294C and PPARGC1A Gly482Ser polymorphisms and physical fitness in Taiwanese late adolescent girls.
    Chiu LL; Chen TW; Hsieh SS; Hsieh LL
    J Physiol Sci; 2012 Mar; 62(2):115-21. PubMed ID: 22247001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser polymorphisms in determining type 2 diabetes intermediate phenotypes in overweight subjects.
    Ruchat SM; Weisnagel SJ; Vohl MC; Rankinen T; Bouchard C; Pérusse L
    Exp Clin Endocrinol Diabetes; 2009 Oct; 117(9):455-9. PubMed ID: 19536736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Peroxisome Proliferator-Activated Receptors and Their Transcriptional Coactivators Gene Variations in Human Trainability: A Systematic Review.
    Petr M; Stastny P; Zajac A; Tufano JJ; Maciejewska-Skrendo A
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29762540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gly482Ser missense mutation of the peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) gene associates with reduced insulin sensitivity in normal and glucose-intolerant obese subjects.
    Fanelli M; Filippi E; Sentinelli F; Romeo S; Fallarino M; Buzzetti R; Leonetti F; Baroni MG
    Dis Markers; 2005; 21(4):175-80. PubMed ID: 16403952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARGC1A genotype (Gly482Ser) predicts exceptional endurance capacity in European men.
    Lucia A; Gómez-Gallego F; Barroso I; Rabadán M; Bandrés F; San Juan AF; Chicharro JL; Ekelund U; Brage S; Earnest CP; Wareham NJ; Franks PW
    J Appl Physiol (1985); 2005 Jul; 99(1):344-8. PubMed ID: 15705733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling Gut Microbiota Signatures Associated with PPARD and PARGC1A Genetic Polymorphisms in a Healthy Population.
    Bailén M; Tabone M; Bressa C; Lominchar MGM; Larrosa M; González-Soltero R
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
    Maver A; Medica I; Salobir B; Tercelj-Zorman M; Sabovic M; Petrovic D; Peterlin B
    Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid-induced differential regulation of the genes encoding peroxisome proliferator-activated receptor-gamma coactivator-1alpha and -1beta in human skeletal muscle cells that have been differentiated in vitro.
    Staiger H; Staiger K; Haas C; Weisser M; Machicao F; Häring HU
    Diabetologia; 2005 Oct; 48(10):2115-8. PubMed ID: 16132959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of obesity associated with the variant allele of the PPARGC1A Gly482Ser polymorphism in physically inactive elderly men.
    Ridderstråle M; Johansson LE; Rastam L; Lindblad U
    Diabetologia; 2006 Mar; 49(3):496-500. PubMed ID: 16474966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the PPARGC1A polymorphism and aerobic capacity in Japanese middle-aged men.
    Nishida Y; Iyadomi M; Higaki Y; Tanaka H; Kondo Y; Otsubo H; Horita M; Hara M; Tanaka K
    Intern Med; 2015; 54(4):359-66. PubMed ID: 25748950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene variants in PPARD and PPARGC1A are associated with timing of natural menopause in the general Japanese population.
    Uemura H; Hiyoshi M; Arisawa K; Yamaguchi M; Naito M; Kawai S; Hamajima N; Matsuo K; Taguchi N; Takashima N; Suzuki S; Hirasada K; Mikami H; Ohnaka K; Yoshikawa A; Kubo M; Tanaka H;
    Maturitas; 2012 Apr; 71(4):369-75. PubMed ID: 22310107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro responsiveness of human muscle cell peroxisome proliferator-activated receptor δ reflects donors' insulin sensitivity in vivo.
    Ordelheide AM; Heni M; Thamer C; Machicao F; Fritsche A; Stefan N; Häring HU; Staiger H
    Eur J Clin Invest; 2011 Dec; 41(12):1323-9. PubMed ID: 21615395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association of regulatory genes polymorphisms with aerobic and anaerobic performance of athletes].
    Akhmetov II; Popov DV; Mozhaĭskaia IA; Missina SS; Astratenkova IV; Vinogradova OL; Rogozkin VA
    Ross Fiziol Zh Im I M Sechenova; 2007 Aug; 93(8):837-43. PubMed ID: 17926914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the CYBA, PPARGC1A, PPARG3, and PPARD gene variants with coronary artery disease and metabolic risk factors of coronary atherosclerosis in a Russian population.
    Nikitin AG; Chistiakov DA; Minushkina LO; Zateyshchikov DA; Nosikov VV
    Heart Vessels; 2010 May; 25(3):229-36. PubMed ID: 20512451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARGC1A sequence variation and cardiovascular risk-factor levels: a study of the main genetic effects and gene x environment interactions in children from the European Youth Heart Study.
    Brito EC; Vimaleswaran KS; Brage S; Andersen LB; Sardinha LB; Wareham NJ; Ekelund U; Loos RJ; Franks PW
    Diabetologia; 2009 Apr; 52(4):609-13. PubMed ID: 19183932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haplotypes of PPARGC1A are associated with glucose tolerance, body mass index and insulin sensitivity in offspring of patients with type 2 diabetes.
    Pihlajamäki J; Kinnunen M; Ruotsalainen E; Salmenniemi U; Vauhkonen I; Kuulasmaa T; Kainulainen S; Laakso M
    Diabetologia; 2005 Jul; 48(7):1331-4. PubMed ID: 15912394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.